Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Insights
  2. Events
  3. About
  4. Contact Us
MAIN/search
MAIN/Insights
Insights/
Our Latest Whitepapers

Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific. 

Learn More
Blogs, Case Studies & Podcasts

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

Discover Insights

IQVIA APAC Insight

"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.

Read The Latest Issue
MAIN/Events
Events/
Upcoming Events & Webinars

View our upcoming events and webinars.

Explore The Latest
On-Demand Webinars

Visit our library of on-demand webinars.

Discover Insights

Featured Event

"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers

Learn More
MAIN/About
About/
Newsroom

Read the latest updates and press releases.

Learn More
Career Opportunities

Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

Search Jobs

APAC FOOTPRINT

"Explore our Asia Pacific locations.

Learn more
MAIN/Contact Us
Contact Us/
WHITE PAPER
Securing Sustainable Reimbursement for Cell and Gene Therapies
May 22, 2023
To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

Cell and gene therapies (CGTs) hold great promise in treating a variety of orphan diseases that previously had no viable cure. With more than 6,000 such diseases afflicting over 350 million patients worldwide, CGTs collectively have the ability to make a substantial impact on society.

However, clinical trial designs, regulation and reimbursement have faced major hurdles that limit patient access to CGTs advancement. This white paper dissects each of these hurdles, challenges within the CGTs reimbursement landscape, and proposed potential solutions to enable patient access to CGTs treatment products with possibly less burden.

For more information, contact us.

Authors

  • Dr. Wang Xueying, Sherry, Principal Director and Head, Regulatory Commercial Services, SEA & APAC RHQ, IQVIA
  • Geraldine John, Manager, Consulting Services, SEA & APAC RHQ, IQVIA
  • Dr. Akansha Gupta, Analyst, Consulting Services, Pricing & Market Access CoE, IQVIA
Contact Us